Residential College | false |
Status | 已發表Published |
Development and marketing strategies of me too drug | |
Su W.-P.1,2; Hu H.1; Shi L.-W.2,3; Wang Y.-T.1,3 | |
2010 | |
Source Publication | Chinese Journal of New Drugs |
Volume | 19Issue:11Pages:926 |
Abstract | Me too drug research has become a famous R&D approach in the world. Pharmaceutical companies adopted myriads of strategies to develop me too drug, such as patent extension, switching to OTC, DTC advertisement and so on. Those strategies could be divided into 3 stages; me too drug discovery, clinical experiments and marketing. This article analyzed enterprise behaviors of three stages under case study to provide references. |
Keyword | Drug Development Marketing Strategy Me Too Drug |
URL | View the original |
Language | 中文Chinese |
The Source to Article | Scopus |
Fulltext Access | |
Document Type | Journal article |
Collection | Institute of Chinese Medical Sciences |
Affiliation | 1.Institute of Chinese Medical Sciences, University of Macau, Macau, China 2.Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China 3.International Research Center for Medicinal Administration, Peking University, Beijing 100191, China |
First Author Affilication | Institute of Chinese Medical Sciences |
Recommended Citation GB/T 7714 | Su W.-P.,Hu H.,Shi L.-W.,et al. Development and marketing strategies of me too drug[J]. Chinese Journal of New Drugs, 2010, 19(11), 926. |
APA | Su W.-P.., Hu H.., Shi L.-W.., & Wang Y.-T. (2010). Development and marketing strategies of me too drug. Chinese Journal of New Drugs, 19(11), 926. |
MLA | Su W.-P.,et al."Development and marketing strategies of me too drug".Chinese Journal of New Drugs 19.11(2010):926. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment